Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Other 1Lymphoid 1

Conditions

Obesity 25Motor Activity 9Breast Neoplasms 9Overweight 6Multiple Endocrine Neoplasia Type 1 4Polycystic Ovary Syndrome 3Neoplasms 3Sexual Dysfunction, Physiological 2Rectal Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Weight Loss 1Urologic Neoplasms 1Urinary Incontinence 1Smoking 1Risk Reduction Behavior 1Prostatic Neoplasms 1Postoperative Complications 1Patient Preference 1Non-alcoholic Fatty Liver Disease 1Malnutrition 1Insulin Resistance 1Inflammation 1Fecal Incontinence 1Fatigue 1Dyspnea 1Dry Eye Syndromes 1Colorectal Neoplasms 1Colonic Neoplasms 1Cancer Patients 1Alcohol Drinking 1

Interventions

Ursodeoxycholic Acid 1Testosterone 1Surveys and Questionnaires 1Medical History Taking 1Hematologic Tests 1Gonadotropin-Releasing Hormone 1Exercise 1Docosahexaenoic Acids 1Colonoscopy 1Blood Pressure 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Non-alcoholic Fatty Liver Disease × Exercise × Other × Clear all
NCT06918080 2025-04-09

Hepatoprotective Measures for Children at High Risk of NAFLD

Ain Shams University

Phase 4 Active not recruiting
200 enrolled
LymphoidOtherOther hematologic neoplasm

Obesity, Overweight, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Non-alcoholic Fatty Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡